No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
APTO Aptose Biosciences
- 1.2310
- -0.0390-3.07%
Close Apr 19 16:00 ET
- 1.2300
- -0.0010-0.08%
Post 17:52 ET
19.35MMarket Cap-162P/E (TTM)
1.2850High1.2300Low36.44KVolume1.2400Open1.2700Pre Close45.38KTurnover0.29%Turnover RatioLossP/E (Static)15.72MShares8.700052wk High-6.65P/B15.42MFloat Cap1.200052wk Low--Dividend TTM12.52MShs Float1457.9988Historical High--Div YieldTTM4.33%Amplitude1.2000Historical Low1.2450Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
What Makes Aptose Biosciences (APTO) a New Buy Stock
Aptose Biosciences Is Maintained at Overweight by Piper Sandler
Aptose Biosciences Is Maintained at Overweight by Piper Sandler
Express News | Piper Sandler Maintains Overweight on Aptose Biosciences, Maintains $5 Price Target
Aptose Biosciences' Strategic Shift to Front-Line AML Therapy Garners Buy Rating
Aptose Biosciences Inc. (NASDAQ:APTO) Q4 2023 Earnings Call Transcript
Aptose Biosciences Is Maintained at Buy by HC Wainwright & Co.
Aptose Biosciences Is Maintained at Buy by HC Wainwright & Co.
Comments
The company is anticipating Payne's expanded role to be significant for their operations and business strategies as Aptose grows in the field of precision oncology.
Press Release: Aptose Appoints Fletcher Payne Chief Business Officer, Expanding His Executive Role 1
$Aptose Biosciences(APTO.US$ RBC Captital maintain Outperform, Speculative/Risk rating and price target of US$5.00.
1
$Aptose Biosciences(APTO.US$ wow didn't see it coming
Watchlist
Penny stocks under $5
APTO
METX-still bullish daily and weekly chart
RWLK- upcoming presentation on the 15th
SNDL
$Aptose Biosciences(APTO.US$ $Meten(METX.US$ $ReWalk Robotics(RWLK.US$ $SNDL Inc(SNDL.US$
APTO
METX-still bullish daily and weekly chart
RWLK- upcoming presentation on the 15th
SNDL
$Aptose Biosciences(APTO.US$ $Meten(METX.US$ $ReWalk Robotics(RWLK.US$ $SNDL Inc(SNDL.US$
14
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg